Clindamycin-induced CovS-mediated regulation of the production of virulent exoproteins streptolysin O, NAD glycohydrolase, and streptokinase in Streptococcus pyogenes

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 1, 2010, Pages 98-102

  Minami, Masaaki ^a   Kamimura, Takuya ^b   Isaka, Masanori ^a   Tatsuno, Ichiro ^a   Ohta, Michio ^b   Hasegawa, Tadao ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; COVS ENZYME; LINCOSAMIDE; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE NUCLEOSIDASE; OLIGONUCLEOTIDE; PROTEIN KINASE; STREPTOKINASE; STREPTOLYSIN O; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; GENETIC TRANSCRIPTION; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS PYOGENES; WESTERN BLOTTING;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LINCOSAMIDES; MICROBIAL SENSITIVITY TESTS; MUTATION; NAD+ NUCLEOSIDASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, BACTERIAL; STREPTOCOCCUS PYOGENES; STREPTOKINASE; STREPTOLYSINS;

EID: 73849092831     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00804-09     Document Type: Article

References (25)

1. Aziz, R. K., M. J. Pabst, A. Jeng, R. Kansal, D. E. Low, V. Nizet, and M. Kotb. 2004. Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol. Microbiol. 51:123-134.
2. B-dependent general and multiple stress response. J. Bacteriol. 184:459-467.
3. Billington, S. J., B. H. Jost, and J. G. Songer. 2000. Thiol-activated cytolysins: structure, function and role in pathogenesis. FEMS Microbiol. Lett. 182:197-205.
4. +-glycohydrolase acts as an intracellular toxin to enhance the extracellular survival of group A streptococci. Mol. Microbiol. 44:257-269.
5. CLSI/NCCLS. 2003. Method for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard M7-A6, 6th ed. CLSI/ NCCLS, Wayne, PA.
6. Coyle, E. A., R. Cha, and M. J. Rybak. 2003. Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin A release. Antimicrob. Agents Chemother. 47:1752-1755.
7. Cunningham, M. W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511.
8. Dalton, T. L., and J. R. Scott. 2004. CovS inactivates CovR and is required for growth under conditions of general stress in Streptococcus pyogenes. J. Bacteriol. 186:3928-3937.
9. Dalton, T. L., R. I. Hobb, and J. R. Scott. 2006. Analysis of the role of CvR and CovS in the dissemination of Streptococcus pyogenes in invasive skin disease. Microb. Pathog. 40:221-227.
10. Graham, M. R., L. M. Smoot, C. A. Migliaccio, K. Virtaneva, D. E. Sturdevant, S. F. Porcella, M. J. Federle, G. J. Adams, J. R. Scott, and J. M. Musser. 2002. Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc. Natl. Acad. Sci. U. S. A. 99:13855-13860.
11. 2+. Proc. Natl. Acad. Sci. U. S. A. 100:4227-4232.
12. 2+ signaling defines the group A streptococcal CsrRS (CovRS) regulon. Mol. Microbiol. 65:671-683.
13. Gryllos, I., H. J. Trans-Winkler, M. F. Cheng, H. Chung, R. Bolcome III, W. Lu, R. I. Lehrer, and M. R. Wessels. 2008. Induction of group A Streptococcus virulence by a human antimicrobial peptide. Proc. Natl. Acad. Sci. U. S. A. 105:16755-16760.
14. Herbert, S., P. Barry, and R. P. Novick. 2001. Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus. Infect. Immun. 69:2996-3003.
15. Ikebe, T., K. Hirasawa, R. Suzuki, J. Isobe, D. Tanaka, C. Katsukawa, R. Kawahara, M. Tomita, K. Ogata, M. Endoh, R. Okuno, H. Watanabe, and the Working Group for Group A Streptococci in Japan. 2005. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infection. Antimicrob. Agents Chemother. 49:788-790.
16. Lappin, E., and A. J. Ferguson. 2009. Gram-positive toxic shock syndrome. Lancet Infect. Dis. 9:281-290.
17. Reference deleted.
18. Mascini, E. M., M. Jansze, L. M. Schouls, J. Verhoef, and H. Van Dijk. 2001. Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci. Int. J. Antimicrob. Agents 18:395-398.
19. Reference deleted.
20. Richter, S. S., K. P. Heilmann, S. E. Beekmann, N. J. Miller, A. L. Miller, C. L. Rice, C. D. Doern, S. D. Reid, and G. V. Doern. 2005. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin. Infect. Dis. 41:599-608.
21. Sawai, J., T. Hasegawa, T. Kamimura, A. Okamoto, D. Ohmori, and M. Ohta. 2007. Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes. Antimicrob. Agents Chemother. 51: 461-467.
22. Sun, H., U. Ringdahl, J. W. Homeister, W. P. Fay, N. C. Engleberg, and A. Y. Yang. 2004. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 305:1283-1286.
23. Tamayo, J., E. Perez-Trallero, J. L. Gomez-Garces, and J. I. Alos on behalf of the Spanish Group for the Study of Infection in the Primary Health Care Setting (IAP-SEIMC). 2005. Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004. J. Antimicrob. Chemother. 56:780-782.
24. Tanaka, M., T. Hasegawa, A. Okamoto, K. Torii, and M. Ohta. 2005. Effect of antibiotics on group A Streptococcus exoprotein production analyzed by two-dimensional gel electrophoresis. Antimicrob. Agents Chemother. 49:88-96.
25. Tension, T., M. Lovmar, and M. Ehrenberg. 2003. The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome. J. Mol. Biol. 330:1005-1014.